India M&A Landscape
A Measured Start to FY 2026-27, Led by Strategic Mega Deals
April 2026
India’s M&A activity opened FY 2026-27 on a selective yet high-impact note, with April witnessing a moderate volume of transactions but strong deal value concentration. The month was defined by large, strategic acquisitions, particularly outbound in nature, as Indian corporates continued to pursue global scale and portfolio diversification.
While overall deal count remained relatively contained, capital deployment skewed heavily toward a few marquee transactions, indicating a shift toward quality over quantity. Sectorally, pharmaceuticals, financial services, and consumer tech remained active, with investors and corporates focusing on consolidation and strategic exits.
Key Highlights
- High-value concentration: A handful of large deals drove the majority of disclosed M&A value
- Outbound momentum: Indian companies actively pursued global acquisitions
- Selective dealmaking: Fewer transactions, but stronger strategic rationale
- Exit activity visible: Secondary stake sales and partial exits gained traction
Notable Transactions
Sun Pharmaceutical Industries – Organon & Co.
One of the largest outbound acquisitions by an Indian company, Sun Pharma announced the acquisition of Organon in a deal valued at $11.75 billion. The transaction significantly strengthens Sun Pharma’s global portfolio and women’s health segment, marking a bold strategic expansion into regulated markets.
Peak XV Partners – MobiKwik
Peak XV executed a partial exit via block deal (₹130 crore) in MobiKwik, reflecting renewed liquidity in public/late-stage tech investments and a gradual normalization of exit cycles.
ICICI Prudential AMC – Strategic Stake Transactions
The month also saw institutional stake reshuffling in financial services, with large investors recalibrating exposure in listed asset management platforms-highlighting continued interest in India’s long-term wealth management story.
Sectoral Trends
Pharmaceuticals & Healthcare
Dominated the month, driven by global expansion strategies and scale-driven acquisitions.
Financial Services
Saw stake sales and portfolio realignment, indicating maturity and capital recycling within the sector.
Consumer & Technology
Activity remained measured, with focus shifting from aggressive expansion to profitability and strategic positioning.
Market Outlook
April 2026 signals a disciplined start to the fiscal year, where large, high-conviction deals outweigh broad-based activity. The continued outbound push by Indian corporates, coupled with selective exits by institutional investors, reflects a market that is maturing and becoming more strategic in capital allocation.
Going forward, M&A activity is expected to remain targeted and sector-driven, with pharma, financial services, and industrials likely leading the next wave of consolidation.
